---
title: "Primary Tumor Resection Plus Osimertinib in Advanced EGFR-mutant Non-small Cell Lung Cancer"
date: "2025-09-16T04:00:00.000Z"
publishedDate: "16 septembre 2025"
summary: "Conditions : Non-Small Cell Lung Cancer; EGFR Interventions : Procedure: Surgery; Drug: Osimertinib Sponsors : Jianxing He Not yet recruiting"
importance: ""
sourceUrl: "https://clinicaltrials.gov/study/NCT07177092?term=interventional+radiology&aggFilters=status%3A"
tags: ["France", "Actualité", "ClinicalTrials.gov — ta recherche"]
permalink: "/papers/2025-09-16-primary-tumor-resection-plus-osimertinib-in-advanced-egfr-mutant-non-small-cell-lung-cancer"
imageUrl: ""
imageCredit: ""
---

## L’essentiel

Conditions : Non-Small Cell Lung Cancer; EGFR Interventions : Procedure: Surgery; Drug: Osimertinib Sponsors : Jianxing He Not yet recruiting

## Lien source

https://clinicaltrials.gov/study/NCT07177092?term=interventional+radiology&aggFilters=status%3A
